Literature DB >> 29616601

Does neutrophil to lymphocyte ratio demonstrate deterioration in renal function?

Senol Tonyali1, Cavit Ceylan1, Sedat Yahsi1, Mine Sebnem Karakan2.   

Abstract

INTRODUCTION: Chronic kidney disease (CKD) is a major health issue worldwide, which leads to end-stage renal failure and cardiovascular events. Neutrophil to lymphocyte ratio (NLR) is a surrogate marker of inflammation and has been widely studied in malignancies, hypertension, heart diseases, and vascular diseases. In this study, we aimed to investigate if NLR represents renal reserve and function after partial or radical nephrectomy.
METHODS: We conducted a retrospective study consists of patients who had undergone radical/partial nephrectomy in our hospital and/or who admitted to urology and nephrology clinics as an outpatient. Patients were divided into four groups: Group 1 (n =  46): Healthy controls; Group 2 (n =  50): Patients who had undergone unilateral partial nephrectomy; Group 3 (n =  46): Patients who had gone unilateral nephrectomy; Group 4 (n =  82): Patients who had CKD.
RESULTS: The mean NLR of each group was as follows: Group 1: 2.14 ± 0.73; Group 2: 3.52 ± 3.74; Group 3: 3.64 ± 3.52, and Group 4: 3.53 ± 2.30. NLR was lower in Group 1 compared to other groups but statistically significant difference was observed only between Group 1 (control) and Group 4 (CKD), 2.14 ± 0.73 versus 3.53 ± 2.30 (p = .005). In non-parametric correlation analysis NLR was found negatively correlated with GFR and positively correlated CKD stage (p = .028 for both correlations).
CONCLUSIONS: The NLR may constitute a practical predictor of CKD besides Cr in patients who had undergone partial or radical nephrectomy.

Entities:  

Keywords:  Neutrophil; chronic kidney disease; lymphocyte; nephrectomy; renal failure

Mesh:

Substances:

Year:  2018        PMID: 29616601      PMCID: PMC6014370          DOI: 10.1080/0886022X.2018.1455590

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


Introduction

Chronic kidney disease (CKD) is a major health issue worldwide, which leads to end-stage renal failure and cardiovascular events. There is a steady increase in the number of patients with CKD. The prevalence of CKD in Turkey was 15.7% in a population-based study conducted with 8765 patients. And ∼62,000 patients are on replacement therapy [1]. The role of inflammation in acute kidney injury [2] and end-stage kidney disease (ESKD) is well-recognized [3]. Neutrophil–lymphocyte ratio (NLR) is a surrogate marker of inflammation and has been widely studied in malignancies [4-6], hypertension, heart diseases and vascular diseases [7,8]. In this study, we aimed to investigate if NLR represents renal reserve and function after partial or radical nephrectomy.

Methods

After the institutional review board approval, we conducted a retrospective study consists of patients who had undergone radical/partial nephrectomy in our hospital and/or who admitted to urology and nephrology clinics as an outpatient. Patients were divided into four groups: Group 1 (n = 46): Healthy controls; Group 2 (n = 50): Patients who had undergone unilateral partial nephrectomy; Group 3 (n = 46): Patients who had gone unilateral nephrectomy; Group 4 (n = 82): Patients who had CKD. Neutrophil/Lymphocyte ratio was calculated by means of complete blood count (CBC) values. CBC results at least 1 month after surgery were used for nephrectomy patients. Glomerular filtration rate (GFR) was calculated using Modification of Diet in Renal Disease (MDRD) equation in CKD patients and the patients were divided into five groups according to GFR. Active urinary tract infection was eliminated in all controls by means of urine analyzes and detailed anamnesis. Patients who were still on renal replacement therapy were also excluded from the study. Mean ± standard deviation (SD), minimum and maximum values were used to describe the quantitative variables. Normality assumption was checked by Shapiro–Wilk’s test and it was found that data do not conform normal distribution. Nominal data were compared using the Chi-square test. Threshold was calculated via ROC curves and Youden Index. Comparison of quantitative measurements among patients and controls were assessed with the non-parametric Spearman correlation analysis. Comparison between groups made by using Mann–Whitney U and Kruskal–Wallis tests. Bivariate and multiple regression analyzes were used to analyze factors associated with CKD. predict For all analyzes the IBM-SPSS version 21.0 was used and the statistical significance was set at p < .05.

Results

In total 224 patients were included the study whom 149 (66.5%) were males and 75 (33.5%) were females. There were 46, 50, 46 and 82 subjects in Group 1, Group 2, Group 3 and Group 4, respectively. The distribution of male and females did not differ between the four groups (p = .341). The mean age of the patients was 60 ± 11.2 years. There was no significant difference between Group 1, Group 2, and Group 3 in terms of age (p = 1.0) however the mean age of patients in Group 4 was higher than the mean age of patients Group 1 and Group 2 (p = .00, p = .003, respectively). The mean NLR was 3.2 ± 2.8 and the Cr was 1.5 ± 0.8 mg/dL in the entire cohort. The mean NLR of each group was as follows: Group 1: 2.14 ± 0.73 (median: 2.0); Group 2: 3.52 ± 3.74 (median: 2.1); Group 3: 3.64 ± 3.52 (median: 2.3), and Group 4: 3.53 ± 2.30 (median 2.8). The mean NLR in control group did not differ between males and females, 2.1 ± 0.8 and 2.2 ± 0.5, respectively (p > .05). The mean eGFR value was lowest in Group 4 and highest in Group 2 (Group 1:77.6 ± 17.3 mL/min/1.73 m2, Group 2: 80.1 ± 19.7 mL/min/1.73 m2, Group 3: 53.5 ± 15.4 mL/min/1.73 m2, Group 4: 30.7 ± 10.6 mL/min/1.73 m2. NLR was lower in Group 1 compared to other groups but statistically significant difference was observed only between Group 1 (control) and Group 4 (CKD), 2.14 ± 0.73 vs. 3.53 ± 2.30 (p = .000) (Table 1).
Table 1.

Patient demographics and characteristics.

 Group 1 (n = 46)Group 2 (n = 50)Group 3 (n = 46)Group 4 (n = 82)p value
Age (years)56.1 ± 10.357.2 ± 10.159.3 ± 11.264.1 ± 11.2.000
Sex     
 Male32283158.341
 Female14221524 
GFR (mL/min/1.73 m2)77.6 ± 17.380.1 ± 19.753.5 ± 15.430.7 ± 10.6.00
NLR2.14 ± 0.7 (2)3.52 ± 3.7 (2.1)3.64 ± 3.5 (2.3)3.53 ± 2.3 (2.8) 
NLR < 3.1842 (91.3%)38 (76%)31 (67.4%)46 (56.1%).000
NLR > 3.184 (8.7%)12 (24%)15 (32.4%)36 (43.9%) 
Patient demographics and characteristics. In multiple regression analysis NLR and Cr together was found related with decreased functional nephron reserve such that estimated nephron reserve decreases while group number increases (Table 2).
Table 2.

Effects of Group, Group–Creatinine, Group–GFR and Group?Creatinine-GFR on NLR (regression analysis).

 βSE for βp% change for β
Group0.1090.035.002 
Group0.0620.041.13043.12
Creatinine0.1170.055.034 
Group0.0870.043.04420.13
GFR–0.0020.002.370 
Group0.0740.043.08732.11
Creatinine0.1670.079.034 
GFR0.0020.003.374 
Effects of Group, Group–Creatinine, Group–GFR and Group?Creatinine-GFR on NLR (regression analysis). The cutoff value for NLR associated with CKD (GFR< 60 mL/min/1.73 m2) was 3.18, with 39% sensitivity and 81% specificity (p = .11). 67 patients had a NLR value >3.18 and 157 patients had a NLR value <3.18. To have a NLR value >3.18 was associated with 2.8-fold increased risk to have CKD [95% CI (lower: 1.5; upper: 5.2)]. In non-parametric correlation analysis NLR was found negatively correlated with GFR and positively correlated CKD stage (p = .028 for both correlations; Table 3).
Table 3.

The correlation analysis of NLR, GFR and CKD stage.

 NLRGFRCKD stage
Spearman’s rho
 NLR   
  Correlation coefficient1.000−.164a.164a
  Sig. (two-tailed) .028.028
  N178178178
 GFR   
  Correlation coefficient−.164a1.000−.943b
  Sig.(two-tailed).028 .000
  N178178178
 CKD stage   
  Correlation coefficient.164a−.943b1.000
  Sig.(two-tailed).028.000 
  N178178178

Correlation is significant at the 0.05 level (two-tailed).

Correlation is significant at the 0.01 level (two-tailed).

The correlation analysis of NLR, GFR and CKD stage. Correlation is significant at the 0.05 level (two-tailed). Correlation is significant at the 0.01 level (two-tailed).

Discussion

NLR is a widely utilized biomarker of systemic inflammation, which can be obtained easily from CBC. Many studies have been conducted to demonstrate the value of NLR in various conditions such as hypertension [7], cardiac disorders [8], malignancies [4-6,9-11], and renal failure [3,12-14]. Inflammation has proven to be associated with CKD and CKD patients has shown to posses a low-grade inflammatory status [15]. NLR was found increased in patients not only receiving hemodialysis but also in predialysis term [13,15,16]. And also improvement of inflammation status according to NLR was better in preemptive renal transplant patients compared to non-preemptive patients at the end of the first year post-renal transplantation [16]. Some researchers have reported that NLR and platelet–lymphocyte ratio (PLR) are positive correlated with inflammatory markers in patients with ESKD [14,17,18]. Ahbap et al. reported that patients with higher CRP (C-reactive protein) levels >3 mg/dL had higher NLR and PLR levels compared to patients with lower CRP levels [NLR (3.7 ± 0.2 vs. 2.7 ± 0.2, p < .01) and PLR (150.7 ± 6.9 vs. 111.8 ± 7.0, p < .001)] [17]. In a study by Turkmen et al., NLR >3.5 was found associated with increased level of TNF-α but not with CRP and IL-6 in patients with ESKD [14]. In another study, PLR was positively correlated with NLR, IL-6, and TNF (p < .001, p = .03, p = .008, respectively) and the authors concluded that PLR was superior to NLR in terms of inflammation in patients with ESKD [18]. NLR was also found associated with cardiovascular and all-cause mortality in hemodialysis patient (p = .0040 and p = .0021, respectively) [3]. Although there has been numerous studied in the literature regarding to association between inflammation and NLR in ESKD, there is not any about the possible relation between renal reserve and NLR. In the present study, we found NLR to be significantly higher in patients with CKD compared to controls. And also NLR was found associated with the stage of CKD. Renal cell carcinoma accounts for 2–3% of all cancers. RCC is the most common solid lesion within the kidney and represents 90% of all renal malignancies [19]. While radical nephrectomy (RN) is indicated for T2 tumors (tumor >7 cm), nephron-sparing surgery is the standard treatment for localized T1a-b tumors (tumors <7 cm) [19]. Because when achieving RCC free status, preserving of the renal function must be the core topic of the process. In previous studies, NSS was reported to be associated with preserved renal function compared to RN [20,21]. In the present study, we found NLR to be associated with GFR. This is the first study in the literature reporting the predictive value NLR on GFR in nephrectomy patients. In this manner, it might be possible to predict renal reserve and function by means of NLR after partial or radical nephrectomy. Our study is not without limitations. First of all, this is a retrospective study. Given the retrospective nature of the study, it was not possible to obtain other inflammatory markers such as CRP, TNF-α and IL-6. And also the sample size of patients in each CKD stage group was small which weakened the power of some statistical analysis.

Conclusions

The NLR may constitute a practical predictor of CKD besides Cr in patients who had undergone partial or radical nephrectomy. This is the first study in the literature demonstrating the predictive value NLR in proceeding to CKD. Larger, prospective studies including the long-term NLR, other inflammatory markers and renal functions values of nephrectomy patients are mandatory to establish definitive criteria.
  21 in total

1.  Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure.

Authors:  P Stenvinkel; O Heimbürger; F Paultre; U Diczfalusy; T Wang; L Berglund; T Jogestrand
Journal:  Kidney Int       Date:  1999-05       Impact factor: 10.612

2.  Neutrophil-Lymphocyte Ratio Is Significantly Decreased in Preemptive Renal Transplant Patients.

Authors:  E Çankaya; Y Bilen; M Keles; A Uyanik; N Bilen; B Aydınlı
Journal:  Transplant Proc       Date:  2015-06       Impact factor: 1.066

3.  The relationship between neutrophil-to-lymphocyte ratio and inflammation in end-stage renal disease patients.

Authors:  Kultigin Turkmen; Ibrahim Guney; Fatma Humeyra Yerlikaya; Halil Zeki Tonbul
Journal:  Ren Fail       Date:  2011-12-16       Impact factor: 2.606

Review 4.  EAU guidelines on renal cell carcinoma: 2014 update.

Authors:  Borje Ljungberg; Karim Bensalah; Steven Canfield; Saeed Dabestani; Fabian Hofmann; Milan Hora; Markus A Kuczyk; Thomas Lam; Lorenzo Marconi; Axel S Merseburger; Peter Mulders; Thomas Powles; Michael Staehler; Alessandro Volpe; Axel Bex
Journal:  Eur Urol       Date:  2015-01-21       Impact factor: 20.096

5.  Platelet-to-lymphocyte ratio better predicts inflammation than neutrophil-to-lymphocyte ratio in end-stage renal disease patients.

Authors:  Kultigin Turkmen; Fatih Mehmet Erdur; Fatih Ozcicek; Adalet Ozcicek; Emin Murat Akbas; Aysu Ozbicer; Levent Demirtas; Suleyman Turk; H Zeki Tonbul
Journal:  Hemodial Int       Date:  2013-03-24       Impact factor: 1.812

6.  Neutrophil-to-lymphocyte ratio and platelet-tolymphocyte ratio in evaluation of inflammation in end-stage renal disease.

Authors:  Elbis Ahbap; Tamer Sakaci; Ekrem Kara; Tuncay Sahutoglu; Yener Koc; Taner Basturk; Mustafa Sevinc; Cuneyt Akgol; Arzu O Kayalar; Zuhal A Ucar; Feyza Bayraktar; Abdulkadir Unsal
Journal:  Clin Nephrol       Date:  2016-04       Impact factor: 0.975

7.  Neutrophil/Lymphocyte ratio has no predictive or prognostic value in breast cancer patients undergoing preoperative systemic therapy.

Authors:  Christoph Suppan; Vesna Bjelic-Radisic; Marlen La Garde; Andrea Groselj-Strele; Katharina Eberhard; Hellmut Samonigg; Hans Loibner; Nadia Dandachi; Marija Balic
Journal:  BMC Cancer       Date:  2015-12-29       Impact factor: 4.430

8.  Association Between the Neutrophil/Lymphocyte Ratio and Acute Kidney Injury After Cardiovascular Surgery: A Retrospective Observational Study.

Authors:  Won Ho Kim; Ji Young Park; Seong-Ho Ok; Il-Woo Shin; Ju-Tae Sohn
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

9.  Neutrophil/Lymphocyte Ratio as a Predictor of In-Hospital Major Adverse Cardiac Events, New-Onset Atrial Fibrillation, and No-Reflow Phenomenon in Patients with ST Elevation Myocardial Infarction.

Authors:  Sherif Wagdy; Mohamed Sobhy; Mohamed Loutfi
Journal:  Clin Med Insights Cardiol       Date:  2016-02-10

Review 10.  Pretreatment Neutrophil to Lymphocyte Ratio as a Prognostic Predictor of Urologic Tumors: A Systematic Review and Meta-Analysis.

Authors:  You Luo; Dong-Li She; Hu Xiong; Sheng-Jun Fu; Li Yang
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

View more
  9 in total

1.  Evaluation of Renal Function after Partial Nephrectomy and Detection of Clinically Significant Acute Kidney Injury.

Authors:  Jurijus Makevičius; Albertas Čekauskas; Arūnas Želvys; Albertas Ulys; Feliksas Jankevičius; Marius Miglinas
Journal:  Medicina (Kaunas)       Date:  2022-05-17       Impact factor: 2.948

2.  Impact of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio on 5-Year Clinical Outcomes of Patients with Stable Coronary Artery Disease Undergoing Elective Percutaneous Coronary Intervention.

Authors:  Edoardo Bressi; Fabio Mangiacapra; Elisabetta Ricottini; Ilaria Cavallari; Iginio Colaiori; Giuseppe Di Gioia; Antonio Creta; Marialessia Capuano; Michele Mattia Viscusi; Germano Di Sciascio
Journal:  J Cardiovasc Transl Res       Date:  2018-10-01       Impact factor: 4.132

3.  Effects of ultraviolet-B radiation on physiology, immune function and survival is dependent on temperature: implications for amphibian declines.

Authors:  Niclas U Lundsgaard; Rebecca L Cramp; Craig E Franklin; Lynn Martin
Journal:  Conserv Physiol       Date:  2020-02-11       Impact factor: 3.079

4.  Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in evaluation of inflammation in non-dialysis patients with end-stage renal disease (ESRD).

Authors:  Peiyuan Li; Chenqi Xia; Peng Liu; Zhong Peng; Hong Huang; Juan Wu; Zhangxiu He
Journal:  BMC Nephrol       Date:  2020-11-25       Impact factor: 2.388

5.  Neutrophil-to-lymphocyte ratio and mortality in the United States general population.

Authors:  Minkyo Song; Barry I Graubard; Charles S Rabkin; Eric A Engels
Journal:  Sci Rep       Date:  2021-01-11       Impact factor: 4.996

Review 6.  Neutrophil-to-Lymphocyte Ratio as a Cardiovascular Risk Marker May Be Less Efficient in Women Than in Men.

Authors:  Ljiljana Trtica Majnarić; Silva Guljaš; Zvonimir Bosnić; Vatroslav Šerić; Thomas Wittlinger
Journal:  Biomolecules       Date:  2021-04-02

7.  Correlation between neutrophil-to-lymphocyte ratio and kidney dysfunction in undiagnosed hypertensive population from general health checkup.

Authors:  Chen Chen; Hai Yan Zhao; Yin Hua Zhang
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-12-01       Impact factor: 3.738

8.  Clustering Inflammatory Markers with Sociodemographic and Clinical Characteristics of Patients with Diabetes Type 2 Can Support Family Physicians' Clinical Reasoning by Reducing Patients' Complexity.

Authors:  Zvonimir Bosnic; Pinar Yildirim; František Babič; Ines Šahinović; Thomas Wittlinger; Ivo Martinović; Ljiljana Trtica Majnaric
Journal:  Healthcare (Basel)       Date:  2021-12-06

9.  Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in Nondialysis Chronic Kidney Patients.

Authors:  Gysllene M C Brito; Andrea M M Fontenele; Erika Cristina R L Carneiro; Iara Antonia L Nogueira; Tamires B Cavalcante; André A M Vale; Sally Cristina M Monteiro; Natalino Salgado Filho
Journal:  Int J Inflam       Date:  2021-06-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.